300841: Chengdu Kanghua Biological Products Co., Ltd. - Summary | Jitta

Chengdu Kanghua Biological Products Co., Ltd.

CHN:300841

Price
CN¥57.08
Loss Chance
50.8%
3.58JITTA SCORE
291.23%Over Jitta Line
Jitta Ranking
193 / 487
1,879 / 5,260
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (21)
Recent Business Performance (6)
Financial Strength (78)
Return to Shareholders (39)
Competitive Advantage (31)
Jitta Signs
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
Revenue and EarningRevenue decline from 2022-2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 48.84% in the last year
SG&A to SalesIncreasing
Cash Conversion CycleMore than 1 year
Key Stats
Jitta Score
Jitta Line
3.58
291.23%
3.54
> 1,000%
4.24
> 1,000%
Biotechnology
4.53
53.96%
5.50
138.47%
7.72
18.96%
COMPANY DESCRIPTION
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China.